India has the dubious distinction of having the highest prevalence of vitiligo in the world, estimated at 8.8 per cent (as against the global prevalence of 1 per cent-2 per cent). Every year, over 1 ...

The leading Chronic Urticaria Companies such as Synermore Biologics, Incyte Corporation, Jasper Therapeutics, Novartis, ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...

VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and ...

Incyte's new CEO, Bill Meury, signals a potential strategic pivot toward M&A, leveraging his biopharma acquisition experience ...

What Happened: A notable Form 4 filing on Monday with the U.S. Securities and Exchange Commission revealed that Meury, Chief Executive Officer at Incyte, exercised stock options for 0 shares of INCY, ...

An expert discusses how early diagnosis of vitiligo is primarily important for limiting the area requiring repigmentation, ...

Vitiligo, an autoimmune skin condition causing milky-white patches, arises from melanocyte destruction. It's non-contagious, ...

Shefali Jariwala passes away at 42. The actress suffered from epilepsy for 15 years. Know about the causes, symptoms, and treatment options for this neurological condition and understand what she ...

Learn about various treatment options for rheumatoid arthritis and how they help to manage symptoms, relieve pain, and slow disease progression.

Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo. The FDA has kicked ...

Carrie Kitko, MD, explains that axatilimab maintains strong response rates in patients with chronic graft-versus-host disease (GVHD) regardless of previous treatment lines and emphasizes the need to ...